This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2875) Cancer Self-Management (71) Chemotherapy and Side Effects Management (88) Human Factors and Usability Case Studies (905) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1598)

Published on in Vol 9 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/57659, first published .
Usability and Usefulness of a Symptom Management Coaching System for Patients With Cancer Treated With Immune Checkpoint Inhibitors: Comparative Mixed Methods Study

Usability and Usefulness of a Symptom Management Coaching System for Patients With Cancer Treated With Immune Checkpoint Inhibitors: Comparative Mixed Methods Study

Usability and Usefulness of a Symptom Management Coaching System for Patients With Cancer Treated With Immune Checkpoint Inhibitors: Comparative Mixed Methods Study

Authors of this article:

Savannah Lucia Caterina Glaser1, 2 Author Orcid Image ;   Itske Fraterman3 Author Orcid Image ;   Noah van Brummelen1, 4 Author Orcid Image ;   Valentina Tibollo5 Author Orcid Image ;   Laura Maria Del Campo6 Author Orcid Image ;   Henk Mallo7 Author Orcid Image ;   Sofie Wilgenhof7 Author Orcid Image ;   Szymon Wilk8 Author Orcid Image ;   Vitali Gisko9 Author Orcid Image ;   Vadzim Khadakou9 Author Orcid Image ;   Ronald Cornet1, 2 Author Orcid Image ;   Manuel Ottaviano10 Author Orcid Image ;   Stephanie Medlock1, 11 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Fraterman I, Sacchi L, Mallo H, Tibollo V, Glaser S, Medlock S, Cornet R, Gabetta M, Hisko V, Khadakou V, Barkan E, Del Campo L, Glasspool D, Kogan A, Lanzola G, Leizer R, Ottaviano M, Peleg M, Śniatała K, Lisowska A, Wilk S, Parimbelli E, Quaglini S, Rizzo M, Locati L, Boekhout A, van de Poll-Franse L, Wilgenhof S. Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective Pilot Study. JMIR Cancer 2025;11:e58938 View